Congress has several competing proposals for what happens next to hemp-derived cannabinoid products. That is the important fact. A federal “hemp rescue” may emerge after the November 3 midterms, but as of November 1 there is no enacted fix and no reason to treat any industry’s preferred framework as inevitable.
The useful question is no longer whether Congress will revisit hemp. It is which products lawmakers are willing to preserve, under what rules, and through which legislative vehicle.
Why the original rescue framing was too confident
The U.S. Hemp Roundtable has publicly expressed confidence that Congress will address the issue after the election. That matters because the organization is deeply involved in the negotiations. It is still an advocacy forecast, not a legislative outcome.
The earlier version of this article leaned too heavily on that forecast. A better reading is that the negotiations have narrowed into identifiable policy choices: CBD, intoxicating beverages, state authority, product standards, taxation and the treatment of inhalable products.
The HEMP Act focuses on non-intoxicating products
Representatives Morgan Griffith and Marc Veasey introduced the Hemp Enforcement, Modernization, and Protection Act of 2026, or HEMP Act. The bill would create a federal pathway for specified non-intoxicating hemp-derived cannabinoid products and direct FDA to establish a regulatory framework.
That approach reflects one of the clearest political dividing lines in the debate: lawmakers who want to preserve CBD and other non-intoxicating products do not necessarily support preserving every intoxicating product currently sold under the hemp definition.
Other proposals tackle intoxicating hemp differently
The Hemp Safety Enforcement Act, introduced by Senators Amy Klobuchar and Rand Paul, would create a federal regulatory structure while preserving significant state authority. The Lawful Hemp Protection Act from Representatives Andy Barr and Angie Craig takes another approach to regulation and taxation.
The Beverage Regulatory Parity Act, introduced by Representatives Beth Van Duyne and Greg Landsman, is especially important for hemp-derived THC beverages. Its basic premise is that intoxicating hemp beverages should be brought into a regulated federal system rather than simply erased from the market.
The emerging policy question is regulatory parity
The strongest version of a hemp fix should not depend on pretending all hemp products carry the same risk. CBD oil, a low-dose THC beverage, a high-potency edible and an inhalable product are different product categories even when federal law traces them back to the same plant definition.
A durable framework can therefore distinguish among products while applying familiar consumer protections where intoxication is involved: age restrictions, accurate potency testing, serving-size rules, child-resistant or otherwise appropriate packaging, manufacturing standards and truthful labeling.
That is the same principle behind my argument that licensed cannabis operators pushing for a blanket hemp-THC ban are making a strategic mistake. Regulatory parity is more defensible than regulatory elimination.
Do not build a business plan around the legislative vehicle yet
Lawmakers and advocates have discussed potential vehicles for moving hemp legislation, including budget-related legislation. But until legislative text is attached to a vehicle that can actually advance, businesses should distinguish lobbying strategy from enacted policy.
That matters especially for operators deciding whether to invest in beverages, CBD, flower, vapes or other hemp-derived products. The proposals do not treat every category the same way. Anyone modeling 2027 revenue should scenario-plan around multiple outcomes rather than assuming Congress will preserve today’s market.
What to watch after the midterms
Four signals matter most: which proposal becomes the negotiating base, whether intoxicating beverages receive a regulated pathway, how much authority remains with individual states, and whether lawmakers separate inhalable products from ingestible products.
The fifth is timing. Businesses do not operate on congressional talking points. They need enough certainty to make inventory, manufacturing, distribution and investment decisions before statutory deadlines arrive.
For broader analysis of cannabis markets and federal policy, visit Cannabis Business.
Frequently Asked Questions
- Has Congress passed a federal hemp fix? No. Multiple proposals are in play, but no new rescue framework described here has been enacted as of November 1, 2026.
- Is CBD likely to be treated differently from intoxicating hemp? Several proposals explicitly distinguish non-intoxicating cannabinoid products from intoxicating products, making separate treatment a central part of the debate.
- Could hemp-derived THC beverages survive? Yes, depending on the legislation Congress ultimately adopts. The Beverage Regulatory Parity Act specifically proposes a regulated pathway for intoxicating hemp beverages.
- Are flower and vapes guaranteed protection? No. Businesses should not assume every hemp-derived product category will receive the same federal treatment.
- What should hemp businesses do now? Track the actual legislative text and model multiple regulatory outcomes rather than treating advocacy predictions as settled law.
Primary sources: Congress.gov — HEMP Act; Congress.gov — Hemp Safety Enforcement Act; Congress.gov — Lawful Hemp Protection Act; Congress.gov — Beverage Regulatory Parity Act. Additional reporting: MJBizDaily.